Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-12-18

Clinical Trial Update: Targeting Dopamine Therapy in RLS [NA]

View source ↗

Summary

This clinical trial update discusses a dopamine-targeting therapy approach for Restless Legs Syndrome, with the trial status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Tel-Aviv Sourasky Medical Center | Conditions: Restless Legs Syndrome | NA | Status: UNKNOWN